mRNA levels of these GBM tissues were higher than the average of normal brain tissues while the green bars (<0) represent GBM sample with lower NMI mRNA expression compared to normal tissues. (B) NMI mRNA expression levels were compared between normal samples and different molecular subtypes of GBMs as indicated (the Agilent platform). (C) NMI expression was compared according to subtype (proneural or not), Glioma-CpG Island Methylation Phenotype (G-CIMP) and IDH1 mutation status (the Agilent platform). (D) The correlations of NMI methylation levels (presented as β values) and NMI expression for both platforms (upper panel, Affymetrix; lower panel, Agilent) were analyzed. (E) NMI expression was compared according to status of PTEN (left panel) or EGFR (right panel) mutation as indicated. Statistical differences were determined by two tailed student's t-test. *, P<0.05; **, P<0.01; ***, P<0.001; ns, not significant. (F) Kaplan-Meier plots were estimated according to different NMI gene expression for overall survival (upper panels) and progression-free survival (lower panels) of all GBM patients (left panels), or considering the mutation status of PTEN (center panels) or EGFR (right panels) simultaneously, in the TCGA cohort (the Agilent platform). P values were obtained from log-rank test.
Supplementary Figure S2 : Overexpression and knockdown of NMI were validated at mRNA level. NMI was overexpressed (upper panels) or knocked down (lower panels) by lentiviruses carrying corresponding expression vectors or shRNAs in U251 (left panels) or U87 (right panels) human glioma cell lines. RNA was extracted and subjected to real-time PCR assay. GAPDH was used as an internal control. Data are presented as mean ± SEM. Statistical analysis was determined by two tailed student's t-test. *, P<0.05. Supplementary Figure S4 : The mRNA expression of NMI and TCTN1 for each GBM patient of the TCGA cohort (A, the Affymetrix platform; B, the Agilent platform) was shown in scatter plots and the Pearson r and P value of the correlation were indicated. The dashed red line was fit by a linear regression.
Supplementary Figure S5 : Knockdown of STAT1 was validated at mRNA and protein levels. STAT1 was knocked down by lentiviruses carrying two independent shRNAs against it, and the efficiency was validated at mRNA level by real-time PCR (A) and protein level by Western blot assays (B). GAPDH was used as an internal control for real time PCR assays and ACTIN as a loading control for Western blot assays. Data are presented as mean ± SEM. Statistical analysis was determined by two tailed student's t-test. *, P<0.05. 
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